Question

Anti PD-L1 medications work by: A. blocking the CTLA-4 protein on the T cell, allowing it to kill the cancer cell. B. binding with PD-L1, preventing deactivation of the T cell. C. presenting LAG-3 to the checkpoint, preventing immunity from being turned off. D. interrupting acquired cellular immunity, resulting in apoptosis.

          Anti PD-L1 medications work by:
A. blocking the CTLA-4 protein on the T cell, allowing it to kill the cancer cell.
B. binding with PD-L1, preventing deactivation of the T cell.
C. presenting LAG-3 to the checkpoint, preventing immunity from being turned off.
D. interrupting acquired cellular immunity, resulting in apoptosis.

Anti PD-L1 medications work by:
A. blocking the CTLA-4 protein on the T cell, allowing it to kill the cancer cell.
B. binding with PD-L1, preventing deactivation of the T cell.
C. presenting LAG-3 to the checkpoint, preventing immunity from being turned off.
D. interrupting acquired cellular immunity, resulting in apoptosis.

Added by Elizabeth M.

Biology for AP Courses

Julianne Zedalis, John Eggebrecht

Instant Answer

Solved by Expert Suman K

Step 1

The question asks how anti PD-L1 medications work. This involves knowing the mechanism of action of these medications in the context of cancer treatment. Show more…

Show all steps

Thanks for your feedback!

Anti PD-L1 medications work by: A. blocking the CTLA-4 protein on the T cell, allowing it to kill the cancer cell. B. binding with PD-L1, preventing deactivation of the T cell. C. presenting LAG-3 to the checkpoint, preventing immunity from being turned off. D. interrupting acquired cellular immunity, resulting in apoptosis.